DR.MAX secures contract for Antineoplastic and immunomodulating agents framework agreement for the supply of medicines from the group ANTINEOPLASICS AND IMMUNOMODULATORS - SACITUZUMAB GOVITECAN POWDER PT CONC PT SOL PERF 200 MG

Romania, April 28 -- Romania based DR.MAX has secured contract from Operator SEAP for Antineoplastic and immunomodulating agents framework agreement for the supply of medicines from the group ANTINEOPLASICS AND IMMUNOMODULATORS - SACITUZUMAB GOVITECAN POWDER PT CONC PT SOL PERF 200 MG. The value of the contract is worth 23291650 RON.

Published by HT Digital Content Services with permission from Pivotal Sources....